BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 26567998)

  • 1. Helicobacter pylori-negative Differentiated Adenocarcinoma of the Stomach.
    Nagaya T; Tanaka N; Iwaya Y; Jimbo Y; Tatai T; Ito T; Seki A; Suzawa K; Ochi Y; Hara E; Takata M; Otsuki T; Iwaya M; Hosaka N; Arakura N; Tanaka E; Hasebe O
    Intern Med; 2015; 54(22):2857-62. PubMed ID: 26567998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A case of Helicobacter pylori-negative intramucosal well-differentiated gastric adenocarcinoma with intestinal phenotype.
    Ozaki Y; Suto H; Nosaka T; Saito Y; Naito T; Takahashi K; Ofuji K; Matsuda H; Ohtani M; Hiramatsu K; Nemoto T; Imamura Y; Nakamoto Y
    Clin J Gastroenterol; 2015 Feb; 8(1):18-21. PubMed ID: 25566739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Helicobacter pylori-negative Gastric Adenocarcinoma Mimicking Verrucous Gastritis in the Antrum: A Case Report and Literature Review.
    Murawaki Y; Yashima K; Horie S; Miura M; Kato J; Hirai T; Takeda K; Kono M; Yoshida M; Isomoto H
    Intern Med; 2023 Jul; 62(14):2063-2069. PubMed ID: 36450460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endoscopic and clinicopathological features of intramucosal, histologically mixed-type, low-grade, well-differentiated gastric tubular adenocarcinoma with the potential for late-onset lymph node metastasis.
    Saitoh T; Takamura A; Watanabe G
    BMC Gastroenterol; 2018 Dec; 18(1):189. PubMed ID: 30587141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mucin phenotype and background mucosa of intramucosal differentiated-type adenocarcinoma of the stomach.
    Sasaki A; Kitadai Y; Ito M; Tanaka S; Yoshihara M; Haruma K; Chayama K
    Oncology; 2004; 66(5):379-87. PubMed ID: 15331925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Re-evaluation of phenotypic expression in undifferentiated-type early gastric adenocarcinomas using mucin core protein and CDX2.
    Ikarashi S; Nishikura K; Ajioka Y; Aoyagi Y
    Gastric Cancer; 2013 Apr; 16(2):208-19. PubMed ID: 22829163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical Expressions of MUC2, MUC5AC, and MUC6 in Normal, Helicobacter pylori Infected and Metaplastic Gastric Mucosa of Children and Adolescents.
    Park JS; Yeom JS; Seo JH; Lim JY; Park CH; Woo HO; Youn HS; Jun JS; Park JH; Ko GH; Baik SC; Lee WK; Cho MJ; Rhee KH
    Helicobacter; 2015 Aug; 20(4):260-8. PubMed ID: 25704078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical evaluation of mucin expression in precancerous tissue of stomach.
    Vernygorodskyi S
    Exp Oncol; 2013 Jun; 35(2):114-7. PubMed ID: 23828387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of intestine-specific transcription factors, CDX1 and CDX2, in intestinal metaplasia and gastric carcinomas.
    Almeida R; Silva E; Santos-Silva F; Silberg DG; Wang J; De Bolós C; David L
    J Pathol; 2003 Jan; 199(1):36-40. PubMed ID: 12474224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intestine-specific homeobox (ISX) induces intestinal metaplasia and cell proliferation to contribute to gastric carcinogenesis.
    Sue S; Shibata W; Kameta E; Sato T; Ishii Y; Kaneko H; Miwa H; Sasaki T; Tamura T; Kondo M; Maeda S
    J Gastroenterol; 2016 Oct; 51(10):949-60. PubMed ID: 26872890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intestinal-type gastric adenocarcinoma without Helicobacter pylori infection successfully treated with endoscopic submucosal dissection.
    Kotani S; Miyaoka Y; Fujiwara A; Tsukano K; Ogawa S; Yamanouchi S; Kusunoki R; Fujishiro H; Kohge N; Ohnuma H; Kinoshita Y
    Clin J Gastroenterol; 2016 Aug; 9(4):228-32. PubMed ID: 27259702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemically detectable Cdx2 is present in intestinal phenotypic elements in early gastric cancers of both differentiated and undifferentiated types, with no correlation to non-neoplastic surrounding mucosa.
    Mizoshita T; Tsukamoto T; Inada K; Ogasawara N; Hirata A; Kato S; Joh T; Itoh M; Yamamura Y; Tatematsu M
    Pathol Int; 2004 Jun; 54(6):392-400. PubMed ID: 15144397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathological features of early gastric cancers arising in
    Sato C; Hirasawa K; Tateishi Y; Ozeki Y; Sawada A; Ikeda R; Fukuchi T; Nishio M; Kobayashi R; Makazu M; Kaneko H; Inayama Y; Maeda S
    World J Gastroenterol; 2020 May; 26(20):2618-2631. PubMed ID: 32523315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatoid adenocarcinoma of the stomach: histogenesis and progression in association with intestinal phenotype.
    Kumashiro Y; Yao T; Aishima S; Hirahashi M; Nishiyama K; Yamada T; Takayanagi R; Tsuneyoshi M
    Hum Pathol; 2007 Jun; 38(6):857-63. PubMed ID: 17320150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mucin phenotype expression of gastric neuroendocrine neoplasms: analysis of histopathology and carcinogenesis.
    Domori K; Nishikura K; Ajioka Y; Aoyagi Y
    Gastric Cancer; 2014 Apr; 17(2):263-72. PubMed ID: 23828549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Helicobacter pylori eradication prevents extension of intestinalization even in the high-risk group for gastric cancer.
    Shiotani A; Nishi R; Uedo N; Iishi H; Tsutsui H; Ishii M; Imamura H; Kamada T; Hata J; Haruma K
    Digestion; 2010; 81(4):223-30. PubMed ID: 20110706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Helicobacter pylori induces gastric mucosal intestinal metaplasia through the inhibition of interleukin-4-mediated HMG box protein Sox2 expression.
    Asonuma S; Imatani A; Asano N; Oikawa T; Konishi H; Iijima K; Koike T; Ohara S; Shimosegawa T
    Am J Physiol Gastrointest Liver Physiol; 2009 Aug; 297(2):G312-22. PubMed ID: 19520737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of Helicobacter pylori Infection on gastric mucin expression.
    Kang HM; Kim N; Park YS; Hwang JH; Kim JW; Jeong SH; Lee DH; Lee HS; Jung HC; Song IS
    J Clin Gastroenterol; 2008 Jan; 42(1):29-35. PubMed ID: 18097286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of gastric gland mucin-specific O-glycan is associated with progression of differentiated-type adenocarcinoma of the stomach.
    Shiratsu K; Higuchi K; Nakayama J
    Cancer Sci; 2014 Jan; 105(1):126-33. PubMed ID: 24138592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Co-expression of CDX2 and MUC2 in gastric carcinomas: correlations with clinico-pathological parameters and prognosis.
    Roessler K; Mönig SP; Schneider PM; Hanisch FG; Landsberg S; Thiele J; Hölscher AH; Dienes HP; Baldus SE
    World J Gastroenterol; 2005 Jun; 11(21):3182-8. PubMed ID: 15929165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.